Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later
Abstract
N-methyl-D-aspartate (NMDA)-receptor antagonists such as ketamine can induce transient schizophrenia-like symptoms and cognitive dysfunctions in healthy volunteers similar to those observed in patients with schizophrenia. Perceptual organization deficits have been documented in schizophrenia and are thought to be related to some symptoms associated with the illness. The current study was designed to determine whether people who repeatedly self-administer ketamine would also show deficits in perceptual organization. Using a psychophysically well-controlled measure of contour integration, we compared a group of recreational users (n = 16) to a group of poly-drug using controls (n = 16). Contour integration performance was measured on the night of drug use and 3 days later when drug free. The results showed that on the night of drug use, ketamine produced a dysfunction in contour integration however, this was not present 3 days later when drug free. Levels of dissociation were also higher in ketamine users only on the night of drug use. These preliminary data provide some support for the role of NMDA-receptor hypofunctioning in dysfunctional coordination of cognitive activity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ketamine's effects include loss of perceptual organization.
“its effects include loss of perceptual organization (Uhlhaas et al., 2007)”
From The Computational Anatomy of Psychosis (2013) · cites this paper as Uhlhaas et al., 2007
Cites
Bremner, J. D., Krystal, J. H., Putnam, F. W., Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024465317902 · Cited by 817 · see citing works
Peters, E. R., Joseph, S. A., & Garety, P. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033401 · Cited by 771 · see citing works
Weak suppression of visual context in chronic schizophrenia
Dakin, S., Carlin, P., & Hemsley, D. (2005) · Current Biology · doi:10.1016/j.cub.2005.10.015 · Cited by 227 · see citing works
Stimulus configuration and context effects in perceptual organization in schizophrenia
Silverstein, S. M., Knight, R. A., Schwarzkopf, S. B., West, L. L., Osborn, L. M., & Kamin, D. (1996) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.105.3.410 · Cited by 191 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Computational Anatomy of Psychosis
Adams, R. A., Stephan, K. E., Brown, H. R., Frith, C. D., & Friston, K. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00047 · Cited by 850 · see citing works
“Ketamine’s reproduction of state symptoms is less consistent: its effects include loss of perceptual organization (Uhlhaas et al., 2007) and induction of a delusional mood (Corlett et al., 2011), but it does not cause a loss of attenuation of self-induced sensations (PC Fletcher, personal…”
BackgroundWhen Doors of Perception Close: Bottom-up Models of Disrupted Cognition in Schizophrenia
Javitt, D. C. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153502 · Cited by 503 · see citing works
Phillips, W. A., Bachmann, T., & Storm, J. F. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00050 · Cited by 62 · see citing works
- Authors
- Uhlhaas, P. J., Millard, I., Muetzelfeldt, L., Curran, H. V., & Morgan, C. J. A.
- Affiliations
- Max Planck Institute for Brain Research (DE)
- Clinical Psychopharmacology Unit, UCL, London, UK.
- University College London (GB)
- Corresponding author
- Morgan, CeLia J.A.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-05
- Volume
- 21
- Issue
- 3
- Pages
- 347-352
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1974169044
- Cited by
- 36
- References
- 4
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 7
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Economic and Social Research Council (RES-000-23-0945)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Keywords
- ketamine, perceptual organization, contour integration, NMDA receptor antagonists, recreational drug use, dissociation, schizophrenia-like symptoms, cognitive impairment, polydrug use
- MeSH terms
- Adolescent, Adult, Amnesia, Delusions, Depersonalization, Dissociative Disorders, Female, Humans, Ketamine, Male, Neuropsychological Tests, Perception, Psychomotor Performance, Visual Perception, Excitatory Amino Acid Antagonists, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review